Allergopharma Overview

  • Year Founded
  • 1969

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 500

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Allergopharma General Information

Description

Provider of allergy treatment products based in Reinbek, Germany. The company operates in the field of allergen immunotherapy and offers high-dose, hypoallergenic, standardized products for the treatment of allergic diseases such as pollen and mite allergies.

Contact Information

Website
allergopharma.dermapharm.com
Formerly Known As
Allergopharma Joachim Ganzer KG
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Hermann-Körner-Street 52
  • 21465 Reinbek
  • Germany
+49 040
Primary Industry
Pharmaceuticals
Parent Company
Dermapharm Holding
Vertical(s)
Life Sciences
Corporate Office
  • Hermann-Körner-Street 52
  • 21465 Reinbek
  • Germany
+49 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Allergopharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Allergopharma‘s full profile, request access.

Request a free trial

Allergopharma Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Allergopharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026220062-A1 Endo-lysosomal-targeted constructs comprising dust mite allergens methods and uses thereof Pending 17-Apr-2025
EP-3825695-A2 Biomarkers for responders to ait Active 25-Nov-2019
EP-3825695-A3 Biomarkers for responders to ait Active 25-Nov-2019
EP-3825695-B1 Biomarkers for responders to ait Active 25-Nov-2019
EP-3825695-C0 Biomarkers for responders to ait Active 25-Nov-2019 G01N33/6863
To view Allergopharma’s complete patent history, request access »

Allergopharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Allergopharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Allergopharma‘s full profile, request access.

Request a free trial

Allergopharma Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
C&L Research Reinbek, Germany 2023

Allergopharma FAQs

  • When was Allergopharma founded?

    Allergopharma was founded in 1969.

  • Where is Allergopharma headquartered?

    Allergopharma is headquartered in Reinbek, Germany.

  • What is the size of Allergopharma?

    Allergopharma has 500 total employees.

  • What industry is Allergopharma in?

    Allergopharma’s primary industry is Pharmaceuticals.

  • Is Allergopharma a private or public company?

    Allergopharma is a Private company.

  • What is the current valuation of Allergopharma?

    The current valuation of Allergopharma is .

  • What is Allergopharma’s current revenue?

    The current revenue for Allergopharma is .

  • Who are Allergopharma’s investors?

    Merck & Co. has invested in Allergopharma.

  • When was Allergopharma acquired?

    Allergopharma was acquired on 31-Mar-2020.

  • Who acquired Allergopharma?

    Allergopharma was acquired by Dermapharm Holding.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process